These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Meloxicam β-cyclodextrin transdermal gel: physicochemical characterization and in vitro dissolution and diffusion studies. Rasool BK, Gareeb RH, Fahmy SA, Rasool AA. Curr Drug Deliv; 2011 Jul; 8(4):381-91. PubMed ID: 21453259 [Abstract] [Full Text] [Related]
3. Formulation of meloxicam gel for topical application: In vitro and in vivo evaluation. Bachhav YG, Patravale VB. Acta Pharm; 2010 Jun; 60(2):153-63. PubMed ID: 21134852 [Abstract] [Full Text] [Related]
4. Rheological behavior of gels and meloxicam release. Ruiz Martinez MA, López-Viota Gallardo J, de Benavides MM, de Dios García López-Duran J, Gallardo Lara V. Int J Pharm; 2007 Mar 21; 333(1-2):17-23. PubMed ID: 17056213 [Abstract] [Full Text] [Related]
5. Formulation optimization of meloxicam sodium gel using response surface methodology. Chang JS, Huang YB, Hou SS, Wang RJ, Wu PC, Tsai YH. Int J Pharm; 2007 Jun 29; 338(1-2):48-54. PubMed ID: 17360134 [Abstract] [Full Text] [Related]
9. Formulation and evaluation of novel controlled release of topical pluronic lecithin organogel of mefenamic acid. Jhawat V, Gupta S, Saini V. Drug Deliv; 2016 Nov 29; 23(9):3573-3581. PubMed ID: 27494650 [Abstract] [Full Text] [Related]
10. Formulation and evaluation of once-a-day transdermal gels of diclofenac diethylamine. Baboota S, Shakeel F, Kohli K. Methods Find Exp Clin Pharmacol; 2006 Mar 29; 28(2):109-14. PubMed ID: 16636721 [Abstract] [Full Text] [Related]
12. Nanoemulsion based gel for transdermal delivery of meloxicam: physico-chemical, mechanistic investigation. Khurana S, Jain NK, Bedi PM. Life Sci; 2013 Mar 14; 92(6-7):383-92. PubMed ID: 23353874 [Abstract] [Full Text] [Related]
13. Development and evaluation of transdermal organogels containing nicorandil. Madan JR, Sagar B, Chellappan DK, Dua K. Antiinflamm Antiallergy Agents Med Chem; 2013 Mar 14; 12(3):246-52. PubMed ID: 23746225 [Abstract] [Full Text] [Related]
15. Development and characterization of a novel controlled release drug delivery system based on nanostructured lipid carriers gel for meloxicam. Khurana S, Jain NK, Bedi PM. Life Sci; 2013 Nov 13; 93(21):763-72. PubMed ID: 24113071 [Abstract] [Full Text] [Related]
16. Formulation and ex vivo evaluation of rofecoxib gel for topical application. Das MK, Ahmed AB. Acta Pol Pharm; 2007 Nov 13; 64(5):461-7. PubMed ID: 18540168 [Abstract] [Full Text] [Related]
17. Evaluation of skin permeation and analgesic activity effects of carbopol lornoxicam topical gels containing penetration enhancer. Al-Suwayeh SA, Taha EI, Al-Qahtani FM, Ahmed MO, Badran MM. ScientificWorldJournal; 2014 Nov 13; 2014():127495. PubMed ID: 25045724 [Abstract] [Full Text] [Related]
18. Development, characterization and in vivo localization study of topical 5-fluorouracil gels: a comparative study with conventional formulation. Jain SK, Puri R. Curr Drug Deliv; 2014 Nov 13; 11(3):401-14. PubMed ID: 24328603 [Abstract] [Full Text] [Related]
19. Release study of diclofenac from new carbomer gels. Bregni C, Chiappetta D, Faiden N, Carlucci A, García R, Pasquali R. Pak J Pharm Sci; 2008 Jan 13; 21(1):12-6. PubMed ID: 18166512 [Abstract] [Full Text] [Related]
20. Ethogel topical formulation for increasing the local bioavailability of 5-fluorouracil: a mechanistic study. Puri R, Jain S. Anticancer Drugs; 2012 Oct 13; 23(9):923-34. PubMed ID: 22926258 [Abstract] [Full Text] [Related] Page: [Next] [New Search]